|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-3-23
|
|
pubmed:abstractText |
Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) effectively interfere with the sympathetic nerve activity in patients with left ventricular (LV) dysfunction. The aim of this study was to examine the effect of ARBs on sympathetic nerve activity and baroreflex function in patients with LV dysfunction already receiving ACE inhibitors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1876-4738
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
171-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19304119-Angiotensin Receptor Antagonists,
pubmed-meshheading:19304119-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:19304119-Arteries,
pubmed-meshheading:19304119-Baroreflex,
pubmed-meshheading:19304119-Drug Synergism,
pubmed-meshheading:19304119-Enalapril,
pubmed-meshheading:19304119-Female,
pubmed-meshheading:19304119-Heart,
pubmed-meshheading:19304119-Hemodynamics,
pubmed-meshheading:19304119-Humans,
pubmed-meshheading:19304119-Lung,
pubmed-meshheading:19304119-Male,
pubmed-meshheading:19304119-Middle Aged,
pubmed-meshheading:19304119-Sympathetic Nervous System,
pubmed-meshheading:19304119-Tetrazoles,
pubmed-meshheading:19304119-Valine,
pubmed-meshheading:19304119-Ventricular Dysfunction, Left
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Augmented sympathoinhibitory effect of valsartan when added to angiotensin-converting enzyme inhibitor in patients with left ventricular dysfunction.
|
|
pubmed:affiliation |
The Second Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
